How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

247 results for

Tinea Corporis

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Pityriasis Rosea (Diagnosis)

, papulosquamous eruption with a duration of 6-8 weeks. It evolves rapidly, usually beginning with patch that heralds the eruption, the so-called “herald patch” (see the image below). It may sometimes occur in atypical variants or may mimic other skin disorders, such as tinea corporis and secondary . [ , , ] Guidelines for diagnosing syphilis (and distinguishing the roseola from pityriasis rosea) have been established. [ ] As a rule, pityriasis rosea requires only symptomatic treatment. Herald patch. Image

2014 eMedicine.com

142. Pityriasis Rotunda (Diagnosis)

. 135(3):491-2. . Gupta S. Pityriasis rotunda mimicking tinea cruris/corporis and erythrasma in an Indian patient. J Dermatol . 2001 Jan. 28(1):50-3. . Sarkany I, Hare PJ. Pityriasis rotunda (pityriasis circinata). Br J Dermatol . 1964 May. 76:223-8. . el-Hefnawi H, Rasheed A. Pityriasis rotunda. "Pseudo-ichtyose acquise en taches circulaires": report and study of first case in UAR. Arch Dermatol . 1966 Jan. 93(1):84-6. . Hasson I, Shah P. Pityriasis rotunda. Indian J Dermatol Venereol Leprol . 2003

2014 eMedicine.com

143. Pityriasis Alba (Diagnosis)

: Will be positive if the patient has tinea versicolor (also called pityriasis versicolor), tinea faciei, or tinea corporis Skin biopsy: Not usually necessary or particularly helpful in establishing a diagnosis of pityriasis alba but may be indicated if a diagnosis of mycosis fungoides (cutaneous T-cell lymphoma) is a significant possibility [ ] See for more detail. Management Pityriasis alba resolves spontaneously; treatment consists primarily of good general skin care and education of a young patient’s parents

2014 eMedicine.com

144. Pityriasis (Diagnosis)

eruption with a duration of 6-8 weeks. It evolves rapidly, usually beginning with patch that heralds the eruption, the so-called “herald patch” (see the image below). It may sometimes occur in atypical variants or may mimic other skin disorders, such as tinea corporis and secondary . [ , , ] Guidelines for diagnosing syphilis (and distinguishing the roseola from pityriasis rosea) have been established. [ ] As a rule, pityriasis rosea requires only symptomatic treatment. Herald patch. Image courtesy

2014 eMedicine.com

145. Pityriasis Rosea (Diagnosis)

, papulosquamous eruption with a duration of 6-8 weeks. It evolves rapidly, usually beginning with patch that heralds the eruption, the so-called “herald patch” (see the image below). It may sometimes occur in atypical variants or may mimic other skin disorders, such as tinea corporis and secondary . [ , , ] Guidelines for diagnosing syphilis (and distinguishing the roseola from pityriasis rosea) have been established. [ ] As a rule, pityriasis rosea requires only symptomatic treatment. Herald patch. Image

2014 eMedicine Pediatrics

146. Pityriasis Alba (Diagnosis)

: Will be positive if the patient has tinea versicolor (also called pityriasis versicolor), tinea faciei, or tinea corporis Skin biopsy: Not usually necessary or particularly helpful in establishing a diagnosis of pityriasis alba but may be indicated if a diagnosis of mycosis fungoides (cutaneous T-cell lymphoma) is a significant possibility [ ] See for more detail. Management Pityriasis alba resolves spontaneously; treatment consists primarily of good general skin care and education of a young patient’s parents

2014 eMedicine Pediatrics

147. Human Immunodeficiency Virus Infection (Diagnosis)

infection Dermatophytosis: Manifesting as an aggressive tinea capitis, corporis, versicolor, or onychomycosis Pneumocystis jiroveci (formerly P carinii ) pneumonia (PCP): Most commonly manifests as cough, dyspnea, tachypnea, and fever Lipodystrophy: Presentations include peripheral lipoatrophy, truncal lipohypertrophy, and combined versions of these presentations; a more severe presentation occurs at puberty Digital clubbing: As a result of chronic lung disease Pitting or nonpitting edema

2014 eMedicine Pediatrics

148. Pityriasis Rosea (Overview)

, papulosquamous eruption with a duration of 6-8 weeks. It evolves rapidly, usually beginning with patch that heralds the eruption, the so-called “herald patch” (see the image below). It may sometimes occur in atypical variants or may mimic other skin disorders, such as tinea corporis and secondary . [ , , ] Guidelines for diagnosing syphilis (and distinguishing the roseola from pityriasis rosea) have been established. [ ] As a rule, pityriasis rosea requires only symptomatic treatment. Herald patch. Image

2014 eMedicine Pediatrics

149. Pityriasis Alba (Overview)

: Will be positive if the patient has tinea versicolor (also called pityriasis versicolor), tinea faciei, or tinea corporis Skin biopsy: Not usually necessary or particularly helpful in establishing a diagnosis of pityriasis alba but may be indicated if a diagnosis of mycosis fungoides (cutaneous T-cell lymphoma) is a significant possibility [ ] See for more detail. Management Pityriasis alba resolves spontaneously; treatment consists primarily of good general skin care and education of a young patient’s parents

2014 eMedicine Pediatrics

150. Pityriasis Alba (Follow-up)

: Will be positive if the patient has tinea versicolor (also called pityriasis versicolor), tinea faciei, or tinea corporis Skin biopsy: Not usually necessary or particularly helpful in establishing a diagnosis of pityriasis alba but may be indicated if a diagnosis of mycosis fungoides (cutaneous T-cell lymphoma) is a significant possibility [ ] See for more detail. Management Pityriasis alba resolves spontaneously; treatment consists primarily of good general skin care and education of a young patient’s parents

2014 eMedicine Emergency Medicine

151. Pityriasis Rosea (Diagnosis)

, papulosquamous eruption with a duration of 6-8 weeks. It evolves rapidly, usually beginning with patch that heralds the eruption, the so-called “herald patch” (see the image below). It may sometimes occur in atypical variants or may mimic other skin disorders, such as tinea corporis and secondary . [ , , ] Guidelines for diagnosing syphilis (and distinguishing the roseola from pityriasis rosea) have been established. [ ] As a rule, pityriasis rosea requires only symptomatic treatment. Herald patch. Image

2014 eMedicine Emergency Medicine

152. Pityriasis Alba (Diagnosis)

: Will be positive if the patient has tinea versicolor (also called pityriasis versicolor), tinea faciei, or tinea corporis Skin biopsy: Not usually necessary or particularly helpful in establishing a diagnosis of pityriasis alba but may be indicated if a diagnosis of mycosis fungoides (cutaneous T-cell lymphoma) is a significant possibility [ ] See for more detail. Management Pityriasis alba resolves spontaneously; treatment consists primarily of good general skin care and education of a young patient’s parents

2014 eMedicine Emergency Medicine

153. Human Immunodeficiency Virus Infection (Overview)

infection Dermatophytosis: Manifesting as an aggressive tinea capitis, corporis, versicolor, or onychomycosis Pneumocystis jiroveci (formerly P carinii ) pneumonia (PCP): Most commonly manifests as cough, dyspnea, tachypnea, and fever Lipodystrophy: Presentations include peripheral lipoatrophy, truncal lipohypertrophy, and combined versions of these presentations; a more severe presentation occurs at puberty Digital clubbing: As a result of chronic lung disease Pitting or nonpitting edema

2014 eMedicine Pediatrics

154. Pityriasis Rosea (Overview)

, papulosquamous eruption with a duration of 6-8 weeks. It evolves rapidly, usually beginning with patch that heralds the eruption, the so-called “herald patch” (see the image below). It may sometimes occur in atypical variants or may mimic other skin disorders, such as tinea corporis and secondary . [ , , ] Guidelines for diagnosing syphilis (and distinguishing the roseola from pityriasis rosea) have been established. [ ] As a rule, pityriasis rosea requires only symptomatic treatment. Herald patch. Image

2014 eMedicine Emergency Medicine

155. Pityriasis Alba (Overview)

: Will be positive if the patient has tinea versicolor (also called pityriasis versicolor), tinea faciei, or tinea corporis Skin biopsy: Not usually necessary or particularly helpful in establishing a diagnosis of pityriasis alba but may be indicated if a diagnosis of mycosis fungoides (cutaneous T-cell lymphoma) is a significant possibility [ ] See for more detail. Management Pityriasis alba resolves spontaneously; treatment consists primarily of good general skin care and education of a young patient’s parents

2014 eMedicine Emergency Medicine

156. A Comparison of DFD01 Spray Versus Vehicle Spray in Subjects With Moderate Psoriasis

the face, scalp, groin, axillae and other intertriginous areas. Subjects must have an IGA grade of 3 (moderate) at the Baseline Visit Exclusion Criteria: Current diagnosis of unstable forms of psoriasis including guttate, erythrodermic, exfoliative or pustular psoriasis Other inflammatory skin disease that may confound the evaluation of the plaque psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis). Presence of pigmentation, extensive scarring, or pigmented lesions or sunburn which

2013 Clinical Trials

157. The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial

, Salmah I. Wound healing activity of Carica papaya L. aqueous leaf extracts in rats. International Journal of Molecular Medicine and Advance Sciences 2005;1(4):398-401. Buensalido JS, Dimagiba TE. The efficacy and safety of 1.5% carica papaya latex cream compared to 2% ketoconazole cream and vehicle in the treatment of tinea corporis: A randomized, double blind, controlled trial. J Phil Dermatol Soc 2011 May;20(1):15-20. Canoy-Valencia H, King-Joanino SVB. An in vitro study of the therapeutic effects

2013 Clinical Trials

158. A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis

. Subjects with psoriasis involving 10 to 20% BSA, not including the face, scalp, groin, axillae and other intertriginous areas. Subjects must have an IGA grade of 3 (moderate) at the Baseline Visit Exclusion Criteria: Current diagnosis of unstable forms of psoriasis including guttate, erythrodermic, exfoliative or pustular psoriasis. Other inflammatory skin disease that may confound the evaluation of the plaque psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis). Presence

2013 Clinical Trials

159. Study Comparing AM001 Cream to Vehicle in the Treatment of Plaque Psoriasis

. Subjects who have a current diagnosis of guttate, pustular, inverse, exfoliative, or erythrodermic psoriasis. Subjects who have a history of psoriasis unresponsive to topical treatments. Subjects who have a history of a disorder that may interfere with the evaluation of plaque psoriasis (e.g., atopic dermatitis, contact dermatitis, tinea corporis, cutaneous lymphoma, etc.). Presence of pigmentation, extensive scarring, or pigmented lesions in the treatment areas, which could interfere with the rating

2013 Clinical Trials

160. Comparison of superficial mycosis treatment using Butenafine and Bifonazole nitrate clinical efficacy. Full Text available with Trip Pro

, parallel-group trial. Of 96 patients, 48 applied (BTF) cream and 48 applied (BFZ) cream for 2 weeks to tinea versicolor, corporis and cruris treat, while tinea of feet & hands was treated for 4 weeks duration. Efficacy was assessed after the end of treatment and 2 weeks later. At the end of therapy, we find somewhat more patients using (BTF) than using (BFZ) had a mycologic cure ((BTF), 87.5%; (BFZ) 83.3%) and effective clinical response ((BTF), 91.7%; (BFZ), 83.3%). (BTF) provides rapid

2013 Global journal of health science Controlled trial quality: uncertain

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>